Subretinal hyperreflective material morphology in neovascular age-related macular degeneration: A case control study

Subretinal hyperreflective material morphology in neovascular age-related macular degeneration: A case control study

Purpose: The aim of this study was to evaluate the association of morphological features of subretinal hyperreflective material (SHRM) with visual acuity (VA), geographic atrophy (GA) and scar formation in eyes with neovascular age-related macular degeneration (neovascular AMD) and to compare with c...

Full description

Bibliographic Details
Main Authors:	Divya Alex, Anantharaman Giridhar, Mahesh Gopalakrishnan, Swati Indurkhya, Shivam Madan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Indian Journal of Ophthalmology
Subjects:	anti-vegf therapy geographic atrophy neovascular age-related macular degeneration scar formation subretinal hyper reflective material visual acuity
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=7;spage=1862;epage=1866;aulast=Alex

Similar Items

Neovascular Remodeling and Subretinal Fibrosis as Biomarkers for Predicting Incomplete Response to Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration
by: Jing Wu, et al.
Published: (2022-04-01)

Hyperreflective material in patients with non-neovascular pachychoroid disease
by: Maiko Maruyama-Inoue, et al.
Published: (2023-06-01)

Iatrogenic choroidal neovascularization associated with subretinal gene therapy surgery
by: Kenneth W. Price, et al.
Published: (2022-09-01)

Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits
by: Dongwan Kang, et al.
Published: (2022-07-01)

Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients
by: Kyung Tae Kim, et al.
Published: (2021-08-01)

Efficacy of a single injection of brolucizumab in neovascular age-related macular degeneration on visual acuity and micromorphometry
by: Shrinivas Joshi, et al.
Published: (2023-01-01)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
by: Daniel Ahmed, et al.
Published: (2020-09-01)

Optical density changes of subretinal hyperreflective material in age-related macular degeneration after switching therapy from ranibizumab to aflibercept
by: Armagan Filik, et al.
Published: (2022-01-01)

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization
by: Müge Çoban Karataş, et al.
Published: (2022-02-01)

Fluorescein angiography of subretinal neovascular membrane in parafoveal telangiectasia type II demonstrating retino-retinal, retino-subretinal anastomosis
by: Bharathi Megur, et al.
Published: (2016-01-01)

Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes
by: Christof Haensli, et al.
Published: (2021-06-01)

The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
by: Henrik Faatz, et al.
Published: (2022-11-01)

Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part I: A Review of Disease Characterization and Morphological Associations
by: Mania Horani, et al.
Published: (2019-03-01)

Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2
by: Kiran Chandran, et al.
Published: (2023-01-01)

Subretinal hyperreflective material in central serous chorioretinopathy
by: Niroj K Sahoo, et al.
Published: (2020-01-01)

Use of ranibizumab for the treatment of subretinal neovascularization in pathologic myopia: a prospective study
by: О.M. Blavatska, et al.
Published: (2016-06-01)

Blockade of Platelet-Derived Growth Factor Signaling Inhibits Choroidal Neovascularization and Subretinal Fibrosis in Mice
by: Ye Liu, et al.
Published: (2020-07-01)

Temporary Vitelliform Regression After Intravitreal Ranibizumab Injection for Macular Neovascularization Complicating Best Disease
by: Fayed A
Published: (2022-10-01)

Subretinal drusenoid deposits: An update
by: Manuel Monge, et al.
Published: (2022-01-01)

Prognostic Optical Coherence Tomography Biomarkers in Neovascular Age-Related Macular Degeneration
by: Baraa Nawash, et al.
Published: (2023-04-01)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
by: Pengxiang Zhou, et al.
Published: (2021-10-01)

Traumatic Macular Hole Repair Following Surgery for Subretinal Hemorrhage
by: Zeynep Alkin, et al.
Published: (2016-12-01)

Comparison of ranibizumab and bevacizumab in neovascular age-related macular degeneration
by: Huseyin Serdarogullari, et al.
Published: (2014-05-01)

Pharmacogenomic study on anti-VEGF medicine in treatment of macular Neovascular diseases: a study protocol for a prospective observational study
by: Jin Jing, et al.
Published: (2018-07-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
by: Reem H. ElSheikh, et al.
Published: (2022-11-01)

Wnt5a/β-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration
by: Dandan Liu, et al.
Published: (2024-03-01)

Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema
by: Shiyue Qin, et al.
Published: (2021-12-01)

Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration
by: Pelin Kıyat, et al.
Published: (2021-06-01)

Hyperreflective Material in Optical Coherence Tomography Images of Eyes with Myopic Choroidal Neovascularization May Affect the Visual Outcome
by: Yasuaki Mushiga, et al.
Published: (2020-07-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
by: Yingbin Fu, et al.
Published: (2024-02-01)

Fenofibrate Inhibits Subretinal Fibrosis Through Suppressing TGF‐β—Smad2/3 signaling and Wnt signaling in Neovascular Age‐Related Macular Degeneration
by: Qian Chen, et al.
Published: (2020-11-01)

Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration
by: Shruti Chandra, et al.
Published: (2023-02-01)

Multimodal imaging of macular subretinal deposits following intravitreal ocriplasmin injection
by: Nicholas Chow, et al.
Published: (2018-03-01)

Morphological characterization of subretinal hyper-reflective material in posterior uveitis using swept-source optical coherence tomography and optical coherence tomography angiography
by: Atul Arora, et al.
Published: (2022-01-01)

Myopic choroidal neovascular membrane: A retrospective study
by: S Sindhu, et al.
Published: (2016-01-01)

Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
by: Benjamin Ng, et al.
Published: (2024-01-01)

Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
by: Federico Ricci, et al.
Published: (2020-11-01)

Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium
by: Dandan Liu, et al.
Published: (2023-09-01)

Subretinal tissue plasminogen-assisted vitrectomy for posttraumatic full-thickness macular hole with submacular hemorrhage
by: Pradeep Kumar, et al.
Published: (2018-01-01)

LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration
by: Lucia Mundo, et al.
Published: (2021-08-01)